Deactylase inhibition in myeloproliferative neoplasms.

Deactylase inhibition in myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q37815421
Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cellsExpression of histone deacetylases in diffuse large B-cell lymphoma and its clinical significanceThe oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML.Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms.Role of epigenetics in chronic myeloid leukemiaSTAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis.Analysis of class I and II histone deacetylase gene expression in human leukemia.Recurring mutations in myeloproliferative neoplasms alter epigenetic regulation of gene expression
P2860

Deactylase inhibition in myeloproliferative neoplasms.

Item
http://www.wikidata.org/entity/Q37815421
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Deactylase inhibition in myeloproliferative neoplasms.
@en
Deactylase inhibition in myeloproliferative neoplasms.
@nl
type
label
Deactylase inhibition in myeloproliferative neoplasms.
@en
Deactylase inhibition in myeloproliferative neoplasms.
@nl
prefLabel
Deactylase inhibition in myeloproliferative neoplasms.
@en
Deactylase inhibition in myeloproliferative neoplasms.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Deactylase inhibition in myeloproliferative neoplasms.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932